AMANDA RYAN: Open Payments
NPI 1124717640 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$842 in 45 payments from 13 companies in 2025. Trend: 2023 $243 · 2024 $1,100 · 2025 $842
Food & beverage: $842
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $279 |
| Novo Nordisk Inc | 9 | $155 |
| ABBVIE INC. | 6 | $115 |
| Stryker Corporation | 2 | $61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $46 |
| Dexcom, Inc. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Lilly USA, LLC | 2 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Abbott Laboratories | 1 | $20 |
Products named: NURTEC ODT, UBRELVY, Wegovy, Ozempic, ELIQUIS, CLOTTRIEVER BOLD CATHETER, QULIPTA, Dexcom G6 Transmitter.
Industry payments across VA — which companies pay providers there.
